I am not a medical person, read the ann carefully and although it did not reflect the excitement of the headline
realised that there was real benefit to be found in the results. Expectations were high and not prepared for anything less,
However Dr B and Ovf, you have both given a balanced and realistic outlook on results, and I also believe that there
would be enough to interest a partnership deal. To sell at this point (especially if at a loss) seems ridiculous because
much more potential here apart from this trial, and if prepared to be patient, profits still to be made. I realise that funds
to cover more research are important, but I still believe the most important outcome of this trial is the fact that sick people
can benefit from the drug. I also wonder about the share dump just before the ann which seems unusual if no prior
knowledge of ann. Anyhow hope some sanity will prevail and shareholders will again see the value here which is
definitely above the SP at present.
- Forums
- ASX - By Stock
- DXB
- Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-214
-
- There are more pages in this discussion • 414 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
42.8¢ |
Change
0.003(0.59%) |
Mkt cap ! $234.0M |
Open | High | Low | Value | Volume |
42.5¢ | 43.0¢ | 42.5¢ | $31.20K | 72.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 97239 | 42.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 18380 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 87325 | 0.425 |
11 | 191729 | 0.420 |
8 | 234053 | 0.415 |
7 | 189807 | 0.410 |
5 | 45102 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 38020 | 1 |
0.435 | 116952 | 5 |
0.440 | 21649 | 3 |
0.445 | 176282 | 7 |
0.450 | 86037 | 6 |
Last trade - 10.04am 12/08/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |